BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29939954)

  • 1. 18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer.
    Sannananja B; Shah HU; Behnia F
    Clin Nucl Med; 2018 Sep; 43(9):695-696. PubMed ID: 29939954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.
    Gill HS; Tade F; Greenwald DT; Yonover PM; Savir-Baruch B
    Clin Nucl Med; 2018 Jan; 43(1):23-24. PubMed ID: 29189374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of 18F-Fluciclovine in Paget Disease.
    Akin-Akintayo OO; Bonta D; Barron B
    Clin Nucl Med; 2019 Nov; 44(11):e614-e616. PubMed ID: 31283597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
    Baiomy A; Jensen CT; Ward JF; Chasen BA; Ravizzini GC
    Clin Nucl Med; 2021 Apr; 46(4):355-357. PubMed ID: 33323736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-Fluciclovine Uptake in Celiac Ganglia: A Pitfall in Prostate Cancer PET Imaging.
    Wo S; Matesan MC
    Clin Nucl Med; 2019 Sep; 44(9):743-745. PubMed ID: 31283598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-Fluciclovine Uptake in Acute Appendicitis.
    Ahn GS; Barsky AR; Galperin-Aizenberg M; Vapiwala N; Pantel AR
    Clin Nucl Med; 2020 Oct; 45(10):e453-e454. PubMed ID: 32701809
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo OO; Tade FI; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Fei B; Schuster DM
    J Nucl Med; 2019 Nov; 60(11):1531-1536. PubMed ID: 30954940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
    Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
    J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT.
    Pernthaler B; Nazerani Hooshmand T; Igrec J; Kvaternik H; Aigner RM
    Clin Nucl Med; 2021 Apr; 46(4):e231-e232. PubMed ID: 33086280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer.
    Abiodun-Ojo OA; Akintayo AA; Harik LR; Bilen M; Halkar RK
    Clin Nucl Med; 2021 May; 46(5):e282-e285. PubMed ID: 33208627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.
    Nguyen NC; Muthukrishnan A; Mountz JM
    Clin Nucl Med; 2020 Jan; 45(1):e63-e64. PubMed ID: 31652158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using
    Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P
    J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective modification of fluciclovine (
    Tade FI; Wiles WG; Lu G; Bilir B; Akin-Akintayo O; Lee JS; Patil D; Yu W; Ormenisan Gherasim C; Fei B; Moreno CS; Osunkoya AO; Teoh EJ; Oka S; Okudaira H; Goodman MM; Schuster DM
    Amino Acids; 2018 Sep; 50(9):1301-1305. PubMed ID: 29905905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Fluciclovine Uptake in a Ureterocele.
    Bitar R; Szklaruk J; Martiniova L; Zurita AJ; Chery LJ; Ravizzini G
    Clin Nucl Med; 2021 Jan; 46(1):e3-e5. PubMed ID: 32956112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Fluciclovine Uptake in Intramuscular Injecting Site of Antiandrogen.
    Hsieh TC; Wu YC; Kao CH; Yen KY; Sun SS
    Clin Nucl Med; 2022 May; 47(5):e401-e402. PubMed ID: 35085174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
    Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
    Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Additional Primary Neoplasms on
    Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
    J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.
    Bitar R; Martiniova L; Bell D; Ravizzini G
    Clin Nucl Med; 2020 Apr; 45(4):e208-e210. PubMed ID: 31977491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT.
    Surasi DSS; Lu Y; Corn P; Pettaway C; Bathala T
    Clin Nucl Med; 2021 Feb; 46(2):e114-e115. PubMed ID: 33156041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.